FFA
GSK icon

Farther Finance Advisors’s GSK GSK Stock Holding History

Farther Finance Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Buy
35,030
+2,201
+7% +$116K 0.01% 790
2026
Q1 		$1.84M Buy
32,829
+3,300
+11% +$179K 0.02% 688
2025
Q4 		$1.45M Buy
29,529
+17,553
+147% +$819K 0.02% 718
2025
Q3 		$517K Buy
11,976
+5,053
+73% +$197K 0.01% 1052
2025
Q2 		$266K Buy
6,923
+838
+14% +$32K 0.01% 1246
2025
Q1 		$230K Buy
6,085
+2,030
+50% +$74.3K 0.01% 1172
2024
Q4 		$137K Sell
4,055
-1,530
-27% -$55.1K 0.01% 1170
2024
Q3 		$228K Sell
5,585
-472
-8% -$19.3K 0.01% 942
2024
Q2 		$232K Buy
6,057
+2,081
+52% +$87.5K 0.01% 780
2024
Q1 		$169K Buy
3,976
+123
+3% +$5.07K 0.01% 744
2023
Q4 		$143K Buy
3,853
+2,037
+112% +$73.1K 0.01% 674
2023
Q3 		$65.8K Buy
1,816
+461
+34% +$16.4K 0.01% 691
2023
Q2 		$48.3K Sell
1,355
-30
-2% -$1.08K 0.01% 684
2023
Q1 		$49.3K Buy
1,385
+1,050
+313% +$36.7K 0.01% 603
2022
Q4 		$11.8K Buy
+335
New +$11.2K ﹤0.01% 893

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

Farther Finance Advisors's GSK Position: Q2 2026 in Review

Farther Finance Advisors increased its GSK (GSK) stake by 6.7% in Q2 2026, buying an estimated $116K and bringing the position to 35,030 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #790.

Farther Finance Advisors first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.84M in Q1 2026. 216 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Farther Finance Advisors held 35,030 shares of GSK worth $1.84M as of Q2 2026.
  • Farther Finance Advisors bought 2,201 GSK shares in Q2 2026, an estimated $116K.
  • GSK made up 0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #790 holding.
  • Farther Finance Advisors first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's GSK position peaked at $1.84M in Q1 2026.
  • 216 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.